Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

JAK1 and JAK2 Modulate Tumor Cell Susceptibility To Natural Killer (NK) Cells Through Regulation Of PDL1 Expression

Roberto Bellucci, PhD, Allison Martin, BS, Davide Bommarito, Kathy S. Wang, PhD, Gordon J Freeman, PhD, Jerome Ritz, MD

Blood (2013) 122 (21): 3472.

https://doi.org/10.1182/blood.V122.21.3472.3472

Published: 2013

Journal Articles

Enhancement of Tumor Cell Susceptibility to NK Cell Activity Through Inhibition of the PI3K Signaling Pathway.

Davide Bommarito, Allison Martin, BS, Maria-Dorothea Nastke, Jerome Ritz, MD, Roberto Bellucci, PhD

Blood (2012) 120 (21): 2152.

https://doi.org/10.1182/blood.V120.21.2152.2152

Published: 2012

Journal Articles

Targeting the Interferon-γ (IFN-γ) Pathway to Enhance Susceptibility of Multiple Myeloma Tumor Cells to NK Cell Lysis

Roberto Bellucci, PhD, Allison Martin, BS, Davide Bommarito, Jerome Ritz, MD

Blood (2012) 120 (21): 4013.

https://doi.org/10.1182/blood.V120.21.4013.4013

Published: 2012

Journal Articles

JAK1 and JAK2 Modulate Myeloma Cell Susceptibility to NK Cells Through the Interferon Gamma (IFN-γ) Pathway,

Roberto Bellucci, PhD, Allison Martin, BS, Marc Buren, Hong-Nam Nguyen, BS, Davide Bommarito, Jerome Ritz, MD

Blood (2011) 118 (21): 3960.

https://doi.org/10.1182/blood.V118.21.3960.3960

Published: 2011

Journal Articles

NOVEL Pathways Modulate TUMOR CELL Susceptibility to NK CELLS.

Roberto Bellucci, Ph.D, Hong-Nam Nguyen, Allison Martin, Anna C. Schinzel, PhD, Stefan Heinrichs, PhD, William C. Hahn, MD, PhD, Jerome Ritz, MD

Blood (2009) 114 (22): 277.

https://doi.org/10.1182/blood.V114.22.277.277

Published: 2009

Journal Articles

Genetic Screening for Myeloma Cell Susceptibility to NK Cell Mediated Lysis Using Large Lentiviral shRNA Libraries

Roberto Bellucci, Ph.D, Hong-Nam Nguyen, Allison Martin, Anna Schinzel, Ph.D, John Daley, Steen Hansen, M.D., Ph.D, William C. Hahn, M.D., Ph.D, Jerome Ritz, M.D.

Blood (2008) 112 (11): 2900.

https://doi.org/10.1182/blood.V112.11.2900.2900

Published: 2008

Journal Articles

Identification of Novel Antigens with Induced Immune Response in MGUS.

Simona Blotta, MD, Hiroshi Yasui, MD, Pierfrancesco Tassone, MD, Roberto Bellucci, PhD, Yu-Tzu Tai, PhD, Rao Prabhala, PhD, Masood A. Shammas, PhD, Pierosandro Tagliaferri, MD, Klaus Podar, MD, PhD, Paola E. Neri, MD, Mariateresa Fulciniti, PhD, Vidit Munshi, Dharminder Chauhan, PhD, Teru Hideshima, MD, PhD, Salvatore Venuta, MD, PhD, Jerome Ritz, MD, Kenneth C. Anderson, MD, Nikhil C. Munshi, MD

Blood (2006) 108 (11): 655.

https://doi.org/10.1182/blood.V108.11.655.655

Published: 2006

Journal Articles

Differential epitope mapping of antibodies to PDC-E2 in patients with hematologic malignancies after allogeneic hematopoietic stem cell transplantation and primary biliary cirrhosis

Roberto Bellucci, Sabine Oertelt, Meagan Gallagher, Sigui Li, Emmanuel Zorn, Edie Weller, Fabrice Porcheray, Edwin P. Alyea, Robert J. Soiffer, Nikhil C. Munshi, M. Eric Gershwin, Jerome Ritz

Blood (2006) 109 (5): 2001–2007.

https://doi.org/10.1182/blood-2006-06-030304

Published: 2006

Journal Articles

IL-2 regulates FOXP3 expression in human CD4 + CD25 + regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo

Emmanuel Zorn, Erik A. Nelson, Mehrdad Mohseni, Fabrice Porcheray, Haesook Kim, Despina Litsa, Roberto Bellucci, Elke Raderschall, Christine Canning, Robert J. Soiffer, David A. Frank, Jerome Ritz

Blood (2006) 108 (5): 1571–1579.

https://doi.org/10.1182/blood-2006-02-004747

Published: 2006

Journal Articles

Patients Who Respond to Donor Lymphocyte Infusion (DLI) Have an Antibody Response Against PDC-E2, the Immunodominant Autoantigens of Primary Biliary Cirrhosis (PBC), but with Different Specificity.

Roberto Bellucci, PhD, Meagan Gallagher, Sabine Oertelt, MD, Emmanuel Zorn, PhD, Edwin P. Alyea, MD, Robert J. Soiffer, MD, Catherine J. Wu, MD, Nikhil C. Munshi, MD, Eric Gershwin, MD, Jerome Ritz, MD

Blood (2005) 106 (11): 3105.

https://doi.org/10.1182/blood.V106.11.3105.3105

Published: 2005

Journal Articles

Identification of Target Antigens Recognized in MGUS for Immunotherapeutic Approaches.

Simona Blotta, MD, Roberto Bellucci, PhD, Pierfrancesco Tassone, MD, Rao Prabhala, PhD, Paola Neri, MD, Masood Shammas, PhD, Ramesh R. Batchu, PhD, Jooeun E. Bae, PhD, Cheng Li, PhD, Salvatore Venuta, MD, Jerome Ritz, MD, Kenneth C. Anderson, MD, Nikhil C. Munshi, MD

Blood (2005) 106 (11): 3463.

https://doi.org/10.1182/blood.V106.11.3463.3463

Published: 2005

Journal Articles

IL-2 Therapy Promotes the Expansion of Human CD4+CD25+ Regulatory T Cells and Selectively Upregulates the Expression of FOXP3 in T Cells In Vivo.

Emmanuel Zorn, PhD, Erik A. Nelson, PhD, Mehrdad Mohseni, MD, Despina Litsa, BSc, Haesook Kim, PhD, Roberto Bellucci, PhD, Fabrice Porcheray, PharmD, Christine Canning, MD, Robert J. Soiffer, MD, Jerome Ritz, MD

Blood (2005) 106 (11): 1257.

https://doi.org/10.1182/blood.V106.11.1257.1257

Published: 2005

Journal Articles

Reduced frequency of FOXP3 + CD4 + CD25 + regulatory T cells in patients with chronic graft-versus-host disease

Emmanuel Zorn, Haesook T. Kim, Stephanie J. Lee, Blair H. Floyd, Despina Litsa, Sankari Arumugarajah, Roberto Bellucci, Edwin P. Alyea, Joseph H. Antin, Robert J. Soiffer, Jerome Ritz

Blood (2005) 106 (8): 2903–2911.

https://doi.org/10.1182/blood-2005-03-1257

Published: 2005

Journal Articles

Graft-versus-tumor response in patients with multiple myeloma is associated with antibody response to BCMA, a plasma-cell membrane receptor

Roberto Bellucci, Edwin P. Alyea, Sabina Chiaretti, Catherine J. Wu, Emmanuel Zorn, Edie Weller, Bingyan Wu, Christine Canning, Robert Schlossman, Nikhil C. Munshi, Kenneth C. Anderson, Jerome Ritz

Blood (2005) 105 (10): 3945–3950.

https://doi.org/10.1182/blood-2004-11-4463

Published: 2005

Journal Articles

Low-Dose Administration of Recombinant IL-2 Following T Cell Depleted Bone Marrow Transplantaion Induces Expansion of CD4+CD25+ FOXP3+ Regulatory T Cells in Vivo.

Emmanuel Zorn, Ph.D., Despina Lista, B.Sc., Haesook Kim, Ph.D., Roberto Bellucci, Ph.D., Christine Canning, M.D., Robert J. Soiffer, M.D., Jerome Ritz, M.D.

Blood (2004) 104 (11): 2136.

https://doi.org/10.1182/blood.V104.11.2136.2136

Published: 2004

Journal Articles

PDC-E2, a Common Auto Antigen in Primary Biliary Cirrhosis (PBC) Is Also a Target of an Antibody Response in Patients Who Achieve Complete Remission after Donor Lymphocyte Infusion.

Roberto Bellucci, Ph.D, Meagan Gallagher, B.S., Hong-Nam Nguyen, Edwin P. Alyea, MD, Emmanuel Zorn, Ph.D, Kenneth C. Anderson, MD, Nikhil C. Munshi, MD, Jerome Ritz, MD

Blood (2004) 104 (11): 2121.

https://doi.org/10.1182/blood.V104.11.2121.2121

Published: 2004

Journal Articles

The Y-Specific Gene PRY Is Expressed in Normal Blood Cells as Well as Leukemia Cells and Can Elicit a Specific Antibody Response in Male Recipients of Hematopoietic Stem Cells from Female Donors.

Emmanuel Zorn, Ph.D., Blair Floyd, B.A, Andrew Tweel, B.A, David B. Miklos, M.D., Ph.D., Roberto Bellucci, Ph.D., Christine Canning, M.D., Robert J. Soiffer, M.D., Joseph Antin, M.D., Jerome Ritz, M.D.

Blood (2004) 104 (11): 4976.

https://doi.org/10.1182/blood.V104.11.4976.4976

Published: 2004

Journal Articles

Complete response to donor lymphocyte infusion in multiple myeloma is associated with antibody responses to highly expressed antigens

Roberto Bellucci, Catherine J. Wu, Sabina Chiaretti, Edie Weller, Faith E. Davies, Edwin P. Alyea, Glenn Dranoff, Kenneth C. Anderson, Nikhil C. Munshi, Jerome Ritz

Blood (2004) 103 (2): 656–663.

https://doi.org/10.1182/blood-2003-07-2559

Published: 2004

Journal Articles

Immunologic effects of prophylactic donor lymphocyte infusion after allogeneic marrow transplantation for multiple myeloma

Roberto Bellucci, Edwin P. Alyea, Edie Weller, Antoinette Chillemi, Ephraim Hochberg, Catherine J. Wu, Christine Canning, Robert Schlossman, Robert J. Soiffer, Kenneth C. Anderson, Jerome Ritz

Blood (2002) 99 (12): 4610–4617.

https://doi.org/10.1182/blood.V99.12.4610

Published: 2002

Journal Articles

BCR-ABL Antisense Oligodeoxynucleotide In Vitro Purging and Autologous Bone Marrow Transplantation for Patients With Chronic Myelogenous Leukemia in Advanced Phase

Paolo de Fabritiis, Maria Concetta Petti, Enrico Montefusco, Maria Stefania De Propris, Roberta Sala, Roberto Bellucci, Marco Mancini, Alessandro Lisci, Francesco Bonetto, Tim Geiser, Bruno Calabretta, Franco Mandelli

Blood (1998) 91 (9): 3156–3162.

https://doi.org/10.1182/blood.V91.9.3156

Published: 1998

NARROW

JAK1 and JAK2 Modulate Tumor Cell Susceptibility To Natural Killer (NK) Cells Through Regulation Of PDL1 Expression

Enhancement of Tumor Cell Susceptibility to NK Cell Activity Through Inhibition of the PI3K Signaling Pathway.

Targeting the Interferon-γ (IFN-γ) Pathway to Enhance Susceptibility of Multiple Myeloma Tumor Cells to NK Cell Lysis

JAK1 and JAK2 Modulate Myeloma Cell Susceptibility to NK Cells Through the Interferon Gamma (IFN-γ) Pathway,

NOVEL Pathways Modulate TUMOR CELL Susceptibility to NK CELLS.

Genetic Screening for Myeloma Cell Susceptibility to NK Cell Mediated Lysis Using Large Lentiviral shRNA Libraries

Identification of Novel Antigens with Induced Immune Response in MGUS.

Differential epitope mapping of antibodies to PDC-E2 in patients with hematologic malignancies after allogeneic hematopoietic stem cell transplantation and primary biliary cirrhosis

IL-2 regulates FOXP3 expression in human CD4 + CD25 + regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo

Patients Who Respond to Donor Lymphocyte Infusion (DLI) Have an Antibody Response Against PDC-E2, the Immunodominant Autoantigens of Primary Biliary Cirrhosis (PBC), but with Different Specificity.

Identification of Target Antigens Recognized in MGUS for Immunotherapeutic Approaches.

IL-2 Therapy Promotes the Expansion of Human CD4+CD25+ Regulatory T Cells and Selectively Upregulates the Expression of FOXP3 in T Cells In Vivo.

Reduced frequency of FOXP3 + CD4 + CD25 + regulatory T cells in patients with chronic graft-versus-host disease

Graft-versus-tumor response in patients with multiple myeloma is associated with antibody response to BCMA, a plasma-cell membrane receptor

Low-Dose Administration of Recombinant IL-2 Following T Cell Depleted Bone Marrow Transplantaion Induces Expansion of CD4+CD25+ FOXP3+ Regulatory T Cells in Vivo.

PDC-E2, a Common Auto Antigen in Primary Biliary Cirrhosis (PBC) Is Also a Target of an Antibody Response in Patients Who Achieve Complete Remission after Donor Lymphocyte Infusion.

The Y-Specific Gene PRY Is Expressed in Normal Blood Cells as Well as Leukemia Cells and Can Elicit a Specific Antibody Response in Male Recipients of Hematopoietic Stem Cells from Female Donors.

Complete response to donor lymphocyte infusion in multiple myeloma is associated with antibody responses to highly expressed antigens

Immunologic effects of prophylactic donor lymphocyte infusion after allogeneic marrow transplantation for multiple myeloma

BCR-ABL Antisense Oligodeoxynucleotide In Vitro Purging and Autologous Bone Marrow Transplantation for Patients With Chronic Myelogenous Leukemia in Advanced Phase

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only